|
|
.
See Category: Neoplasms
See Header: Basal cell carcinoma skin/ ear and external auricular canal
ICD-10 (CM) Code and Descriptor
|
C44.219 |
Basal cell carcinoma of skin of left ear and external auricular canal
|
C44219 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 59.04%
|
21.18%
|
7.46%
|
3.84%
|
1.95%
|
1.58%
|
1.20%
|
0.79%
|
0.77%
|
0.55%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.219*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
3,044
|
4,895
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,774
|
1,778
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
1,487
|
1,546
|
|
17312
|
MOHS ADDL STAGE |
922
|
1,209
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
879
|
1,548
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
777
|
777
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
549
|
15,780
|
|
J3010
|
FENTANYL CITRATE INJECTION |
475
|
715
|
|
15260
|
FTH/GFT FR N/E/E/L 20 SQCM/< |
433
|
432
|
|
J2405
|
ONDANSETRON HCL INJECTION |
391
|
1,624
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
385
|
385
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
375
|
1,417
|
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
357
|
358
|
|
14060
|
TIS TRNFR E/N/E/L 10 SQ CM/< |
343
|
343
|
|
88332
|
PATH CONSLTJ SURG EA ADD BLK |
318
|
613
|
|
17000
|
DESTRUCT PREMALG LESION |
316
|
316
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
281
|
283
|
|
11642
|
EXC F/E/E/N/L MAL+MRG 1.1-2 |
272
|
277
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
259
|
1,887
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
252
|
989
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.219 related to the following DRG Codes:
606-607
|
